Company intelligence / Profile preview

QuantaLife

Pleasanton, California, United States

Ownership: Private
Development stage: Other

Overview

QuantaLife commercialized the Droplet Digital PCR (ddPCR) system, offering the most accurate, cost-effective, and high-resolution genetic analysis platform at commercial scale for research and molecular diagnostics; it won the 2011 North American Frost & Sullivan Award for New Product Innovation[1][3].

Therapeutic areas: OtherRare Diseases
Modalities: DevicePCR-based technology
Industry: Molecular Diagnostics

Beyond the preview

Go deeper on QuantaLife.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on QuantaLife.

Explore the full profile